Back
ESC Professional Premium Access

Impact of nebivolol versus carvedilol on long-term clinical outcomes in STEMI patients treated with drug-eluting stents

Session: New perspectives in cardiology (2) - Expanding pharmacological and non-pharmacological options for coronary disease
Topic: Epidemiology, Prognosis, Outcome
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

6 more presentations in this session

Discussant - Expanding pharmacological and non-pharmacological options for coronary disease

Access
Like
Thumbnail

The effectiveness of allopurinol in improving ischemic symptoms or exercise tolerance in patients with chronic coronary syndromes: a systematic review and meta-analysis of randomized clinical trials

Speaker: Doctor S. Del Vecchio Ziotti (Sao Paulo, BR)

Access
Abstract
Slides
Like
Thumbnail

Baseline characteristics, treatment and mortality among acute myocardial infarction patients with varying left ventricular ejection fractions according to the Estonian Myocardial Infarction Registry

Speaker: Ms J. Smirnova (Tallinn, EE)

Access
Abstract
Like
Thumbnail

Preliminary experience with comprehensive treatment in patients with rapidly progressive coronary artery disease (RP-CAD)

Speaker: Doctor Y. Liu (Beijing, CN)

Access
Abstract
Slides
Like
Thumbnail

Intensified hypolipidaemic therapy with inclisiran for atherosclerotic plaque stabilization

Speaker: Doctor B. Kokina (Riga, LV)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

New perspectives in cardiology (2) - Expanding pharmacological and non-pharmacological options for coronary disease

Speakers: Doctor S. Del Vecchio Ziotti, Ms J. Smirnova, Doctor Y. Liu, Doctor B. Kokina
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

novartis Explore sponsored resources